HFS
ANIK icon

HL Financial Services’s Anika Therapeutics ANIK Stock Holding History

HL Financial Services’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$211K Buy
6,988
+475
+7% +$16.3K ﹤0.01% 695
2018
Q4 		$219K Sell
6,513
-2,298
-26% -$82.9K ﹤0.01% 672
2018
Q3 		$372K Buy
8,811
+911
+12% +$36K 0.01% 594
2018
Q2 		$253K Buy
7,900
+2,071
+36% +$85.3K ﹤0.01% 624
2018
Q1 		$290K Buy
5,829
+115
+2% +$6.5K 0.01% 590
2017
Q4 		$308K Buy
5,714
+821
+17% +$45.4K 0.01% 507
2017
Q3 		$284K Buy
4,893
+178
+4% +$9.3K 0.01% 587
2017
Q2 		$233K Sell
4,715
-47,278
-91% -$2.18M ﹤0.01% 629
2017
Q1 		$2.26M Sell
51,993
-1,939
-4% -$92.6K 0.05% 225
2016
Q4 		$2.64M Sell
53,932
-3,619
-6% -$167K 0.06% 201
2016
Q3 		$2.75M Buy
57,551
+10,920
+23% +$539K 0.06% 187
2016
Q2 		$2.5M Buy
46,631
+4,283
+10% +$202K 0.06% 180
2016
Q1 		$1.89M Buy
42,348
+7,945
+23% +$322K 0.05% 216
2015
Q4 		$1.31M Buy
34,403
+8,131
+31% +$311K 0.03% 270
2015
Q3 		$836K Buy
26,272
+374
+1% +$13K 0.02% 309
2015
Q2 		$855K Buy
25,898
+7,286
+39% +$260K 0.02% 343
2015
Q1 		$766K Buy
18,612
+4,276
+30% +$173K 0.02% 359
2014
Q4 		$584K Buy
+14,336
New +$560K 0.02% 393

Other funds holding ANIK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HL Financial Services's ANIK Position: Q1 2019 in Review

HL Financial Services increased its Anika Therapeutics (ANIK) stake by 7.3% in Q1 2019, buying an estimated $16.3K and bringing the position to 6,988 shares worth $211K. The position accounts for ﹤0.01% of the portfolio, ranked #695.

HL Financial Services first reported a position in ANIK in Q4 2014 and has held it in 18 quarters since. The position peaked at $2.75M in Q3 2016. 157 funds tracked by Wall St. Rank hold ANIK as of Q1 2019.

  • HL Financial Services held 6,988 shares of Anika Therapeutics worth $211K as of Q1 2019.
  • HL Financial Services bought 475 Anika Therapeutics shares in Q1 2019, an estimated $16.3K.
  • Anika Therapeutics made up ﹤0.01% of HL Financial Services's portfolio in Q1 2019, its #695 holding.
  • HL Financial Services first reported a position in Anika Therapeutics in Q4 2014 and has held it in 18 quarters since.
  • HL Financial Services's Anika Therapeutics position peaked at $2.75M in Q3 2016.
  • 157 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2019.

Based on HL Financial Services's 13F filing for Q1 2019, filed 1 May 2019.